May 26, 2022

Oral Ulcer Treatment Market Size by Drug Type Corticosteroid, Antihistamine, Antimicrobial, Analgesic, and Major Formulations Forecast 2018 to 2023

Highlights of the Global Oral Ulcer Treatment Market

Canker sores are painful sores that can develop in the mucous membrane of the oral cavity and limit the ability to chew, bite or eat. Some factors that lead to mouth ulcer are stress, infections, injuries, allergies and others that lead to severe pain. The increasing use of synthetics in oral items such as toothpaste and increasingly unhealthy lifestyle including high consumption of junk food and tobacco are some of the factors driving the growth of this market.

Mouth ulcer can be prevented by avoiding tissue damage, avoiding foods that cause mouth irritation, and maintaining oral hygiene. Besides the traditional method, various drugs are used to treat canker sores. Rising aging population and increasing incidence of canker sores are driving the growth of this market.

However, people’s flippant approach to mouth sores and the lack of awareness that if mouth sore is not treated early it can lead to cancer, these factors can negatively impact the growth of this market.

Get an exclusive copy @


The global oral ulcer treatment market has been segmented on the basis of drug type, formulation, and indication. Based on drug type, the market is segmented into corticosteroids, antihistamines, antimicrobials, pain relievers, and anesthetics. On the basis of formulation, the oral ulcer treatment market is segmented into gel, mouthwash, ointment, spray and lozenges. Based on the indication, the oral ulcer treatment market is segmented into aphthous stomatitis, oral lichen planus, and others.

The market has been segmented, by region, into Americas, Europe, Asia-Pacific, Middle East and Africa.

Key players

The Global Oral Ulcer Treatment Market are Pfizer, Inc., Church & Dwight Co., Inc., 3M, Taro Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, BLISTEX, INC., GlaxoSmithKline plc., ECR Pharmaceuticals, Sannova, Reckitt Benckiser, Sunstar, Blairex Laboratories , Sanjin Pharmaceutical, Joincare Pharmaceutical, Sinclair Pharma, and Colgate-Palmolive Company.

Regional analysis

A growing need for greater appeal to oral hygiene in the area of ​​canker sore treatment is observed around the world. Growing awareness of oral hygiene and increasing incidence of canker sores are factors responsible for the growth of the market in this region.

The Americas market is expected to drive the global oral ulcer treatment market due to advancements in technology and increasing incidence of oral ulcers. This is largely attributed to the accessibility of an urban health infrastructure. The European market is expected to be second due to public funding and support from the health sector, as well as the increasing prevalence of canker sores. Moreover, the growing demand for oral ulcer treatment in developing Asia-Pacific markets has thrived in the area of ​​oral ulcers market. The Middle East and Africa market accounts for the smallest share due to lack of medical technology and poor medical facilities.

Ask the expertise @

About Us:

Market Research Future (MRFR), enables clients to disentangle the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Report (HCRR), Raw Research Report (3R), Research Continuous (CFR) and Market Research and Advisory Services.

Contact us:

Future market research

Office n ° 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Telephone: +1 646 845 9312

Email: [email protected]